Overview
Peter Chi practices practicing medicine in Nankang, Taiwan.
His clinical expertise encompasses Autosomal Recessive Primary Microcephaly and Ovarian Cancer.
He is actively involved in clinical research, co-authoring 39 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Peter Chi
Is Peter Chi a top-rated expert for Autosomal Recessive Primary Microcephaly?
MediFind is an objective health platform that identifies experts based on real-world data. Peter Chi is classified as an Experienced expert for Autosomal Recessive Primary Microcephaly, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Peter Chi participate in research or clinical trials?
Yes. Peter Chi has published 39 articles and abstracts on conditions like Autosomal Recessive Primary Microcephaly. You can view a list of Peter Chi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Autosomal Recessive Primary Microcephaly
- Ovarian CancerMr. Chi isExperienced. Learn about Ovarian Cancer.